| Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients—a systematic review and meta-analysis T Fazekas, AD Szeles, B Teutsch, A Csizmarik, B Vekony, A Varadi, T Koi, ... Prostate Cancer and Prostatic Diseases 26 (4), 665-672, 2023 | 9 | 2023 |
| Poly (ADP-ribose) polymerase inhibitors have comparable efficacy with platinum chemotherapy in patients with BRCA-positive metastatic castration-resistant prostate cancer. a … T Fazekas, ÁD Széles, B Teutsch, A Csizmarik, B Vékony, T Kói, N Ács, ... European Urology Oncology 7 (3), 365-375, 2024 | 7 | 2024 |
| Liquid biopsy for the assessment of adrenal cancer heterogeneity: where do we stand? P Perge, G Nyirő, B Vékony, P Igaz Endocrine 77 (3), 425-431, 2022 | 5 | 2022 |
| MicroRNA-Mediated Suppression of Glial Cell Line-Derived Neurotrophic Factor Expression Is Modulated by a Schizophrenia-Associated Non-Coding Polymorphism G Keszler, B Vékony, Z Elek, Z Nemoda, N Angyal, Z Bánlaki, ... International Journal of Molecular Sciences 25 (8), 4477, 2024 | 1 | 2024 |
| A primer hyperaldosteronismus genetikája B Vékony, P Igaz Orvosi Hetilap 164 (9), 332-338, 2023 | 1 | 2023 |
| The genetic background of primary aldosteronism B Vékony, P Igaz Orvosi Hetilap 164 (9), 332-338, 2023 | 1 | 2023 |
| Circulating miRNAs and Machine Learning for Lateralizing Primary Aldosteronism B Vékony, G Nyirő, Z Herold, J Fekete, F Ceccato, S Gruber, L Kürzinger, ... Hypertension 81 (12), 2479-2488, 2024 | | 2024 |
| P259 The impact of concomitant medication on the efficacy of immune checkpoint inhibitor therapy in patients with urothelial carcinoma T Fazekas, AD Széles, M Váradi, A Csizmarik, BL Vékony, P Rajwa, ... European Urology Open Science 69, 327, 2024 | | 2024 |
| 9305 Circulating MicroRNA-based Biomarker Combinations for Differentiating Uni-and Bilateral Primary Aldosteronism Using a Machine Learning Approach B Vekony, G Nyiro, Z Herold, J Fekete, F Ceccato, S Gruber, L Kurzinger, ... Journal of the Endocrine Society 8 (Supplement_1), bvae163. 567, 2024 | | 2024 |
| miRNA Expression Profiling in G1 and G2 Pancreatic Neuroendocrine Tumors G Nyirő, BK Szeredás, Á Decmann, Z Herold, B Vékony, K Borka, K Dezső, ... Cancers 16 (14), 2528, 2024 | | 2024 |
| Machine learning-based differentiation of uni-and bilateral primary aldosteronism using circulating microRNA combinations B Vekony, G Nyirő, Z Herold, J Fekete, F Ceccato, S Gruber, L Kurzinger, ... Endocrine Abstracts 99, 2024 | | 2024 |
| Differences in the microRNA expression of G1 and G2 pancreatic neuroendocrine tumors G Nyirő, B Szeredás, B Vékony, K Borka, A Zalatnai, K Dezső, I Kovalszky, ... | | |
